Metabolic science has moved rapidly in recent years, and the compound categories generating the most research excitement are those that engage the hormonal systems governing energy balance, insulin regulation, and appetite control. Among the most actively studied compounds in this space are two that have become go to tools for researchers examining these pathways. Tirzepatide and semaglutide represent complementary research tools that, when used together, allow scientists to explore both single and dual receptor biology in controlled experimental settings.